View Author
cancer prostate model biopsy prostate cancer patient nomogram prediction screening study cohort value validation probability level table outcome psa level disease population tumor measure volume decision performance prostate biopsy curve round number regression score kattan erspc european threshold gleason prediction models antigen analysis result fication calibration treatment rotterdam comparison tissue discrimination psa levels prostate cancer risk urology speci stage reclassi steyerberg –75th percentiles difference factor prostate-specific antigen bene fit history variable prediction model prostatectomy statistic risk factors network marker development prostate volume research psa screening predictor scardino pt characteristic slope reclassi fication family history prostate-speci fic antigen article information
8 Most Recent Publications
|
The relationship between prostate-specific antigen and prostate cancer risk: The prostate biopsy collaborative group
(Article)
Vickers, A.J. Cronin, A.M. Parekh, D.J. Ankerst, D. Bartsch, G. Klocker, H. Horninger, W. Benchikh, A. Salama, G. Villers, A. Freedland, S.J. Moreira, D.M. Roobol, M.J. Schröder, F.H. Lilja, H. Hugosson, J. Jones, J.S. Kattan, M.W. Klein, E. Hamdy, F. Neal, D. Donovan, J. |
2010-09-01
|
|
Editorial: What patients newly diagnosed with clinically localized prostate cancer need to see: An editorial dialogue
(Article)
Kattan, M.W. Schröder, F.H. |
2010-08-01
|
|
Author's response: Probabilistic predictions, medical decisions, and clinical usefulness
(Article)
Steyerberg, E.W. Kattan, M.W. Vickers, A.J. |
2010-01-01
|
|
Assessing the performance of prediction models: A framework for traditional and novel measures
(Article)
Steyerberg, E.W. Vickers, A.J. Cook, N.R. Gerds, T.A. Gonen, M. Obuchowski, N. Pencina, M. Kattan, M.W. |
2010-01-01
|
|
The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review
(Article)
Schröder, F.H. Kattan, M.W. |
2008-08-01
|
|
Validation of Pretreatment Nomograms for Predicting Indolent Prostate Cancer: Efficacy in Contemporary Urological Practice
(Article)
Dong, F. Kattan, M.W. Steyerberg, E.W. Jones, J.S. Stephenson, A.J. Schröder, F.H. Klein, E.A. |
2008-07-01
|
|
Nomogram use for the prediction of indolent prostate cancer: Impact on screen-detected populations
(Article)
Roemeling, S. Roobol, M.J. Kattan, M.W. Kwast, Th.H. van der Steyerberg, E.W. Schröder, F.H. |
2007-11-15
|
|
Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram
(Article)
Steyerberg, E.W. Roobol, M.J. Kattan, M.W. Kwast, Th.H. van der Koning, H.J. de Schröder, F.H. |
2007-01-01
|
